Cardiac troponin I is associated with ICU admission in pediatric patients with RSV

Meghan Brown1, Sydney Lawless1, Brittany Roemmich1

  • 1Division of Laboratory and Genomic Medicine, Department of Pathology & Immunology. Washington University in St. Louis, St. Louis, MO, USA.

Clinical Biochemistry
|February 18, 2025
PubMed

Insights

Elevated cardiac troponin I (cTnI) levels in pediatric patients with respiratory syncytial virus (RSV) are linked to intensive care unit (ICU) admission and bronchiolitis. This finding may aid in early prognostication and treatment.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Biomarker research

Background:

  • Respiratory syncytial virus (RSV) causes significant pediatric morbidity and mortality.
  • Limited tools exist for prognosticating RSV outcomes in children.
  • Cardiac troponin I (cTnI) was evaluated as a prognostic biomarker.

Purpose of the Study:

  • To assess the utility of cTnI in predicting intensive care unit (ICU) length of stay (LOS) and bronchiolitis in pediatric patients with RSV.
  • To determine if elevated cTnI levels correlate with severe RSV outcomes.

Main Methods:

  • 114 pediatric patients with RSV and 45 controls were enrolled.
  • High-sensitivity cTnI was measured in plasma samples.
  • Statistical analyses included Fisher's exact test and multivariable logistic regression.

Main Results:

  • 56.9% of ICU-admitted RSV patients had cTnI above the limit of detection (LOD), versus 27.0% of non-ICU patients.
  • Elevated cTnI was associated with increased odds of ICU admission (OR 2.37) and bronchiolitis (OR 2.78).
  • Receiver operator characteristic analysis showed moderate predictive ability for ICU admission (AUC 0.62).

Conclusions:

  • Elevated cTnI levels above the LOD are associated with ICU admission and bronchiolitis in pediatric RSV cases.
  • cTnI shows potential as a prognostic biomarker for severe RSV outcomes.
  • Further research is needed to validate these findings.
Abstract